Perspective Therapeutics (CATX) Change in Receivables (2016 - 2026)

Perspective Therapeutics' Change in Receivables history spans 17 years, with the latest figure at $52000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 236.84% to $52000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$20000.0, a 97.83% increase, with the full-year FY2025 number at -$110000.0, up 89.51% from a year prior.
  • Change in Receivables hit $52000.0 in Q1 2026 for Perspective Therapeutics, up from -$173000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for CATX hit a ceiling of $618000.0 in Q3 2023 and a floor of -$813000.0 in Q2 2024.
  • Historically, Change in Receivables has averaged -$87705.9 across 5 years, with a median of -$46000.0 in 2025.
  • Biggest five-year swings in Change in Receivables: skyrocketed 256.46% in 2023 and later tumbled 16700.0% in 2024.
  • Tracing CATX's Change in Receivables over 5 years: stood at -$245000.0 in 2022, then plummeted by 131.02% to -$566000.0 in 2023, then skyrocketed by 61.66% to -$217000.0 in 2024, then grew by 20.28% to -$173000.0 in 2025, then surged by 130.06% to $52000.0 in 2026.
  • Business Quant data shows Change in Receivables for CATX at $52000.0 in Q1 2026, -$173000.0 in Q4 2025, and -$46000.0 in Q3 2025.